US Patent Issued to The Trustees of Princeton University on July 28 for "Quantitative screen for the assessment of inter-individual variability in drug metabolism by the human gut microbiome" (New Jersey, Arizona Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,529, issued on July 28, was assigned to The Trustees of Princeton University (Princeton, N.J.).

"Quantitative screen for the assessment of inter-individual variability in drug metabolism by the human gut microbiome" was invented by Mohamed Abou Donia (Princeton, N.J.), Bahar Javdan (Fort Lee, N.J.) and Jaime Lopez (Surprise, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a quantitative screen for the assessment of microbiome derived drug metabolism. The disclosed quantitative screen, named MDMQ-Screen, may be employed, inter alia, for assessing the impact of the human gut microbiome on drug metabolism. MDMQ-Screen is used t...